# The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

> **NCT04251520** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Palliative Medicine

## Interventions

- **DIAGNOSTIC_TEST:** Pharmacogenomics testing
- **OTHER:** Pharmacist review

## Key facts

- **NCT ID:** NCT04251520
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-15
- **Primary completion:** 2022-01-12
- **Final completion:** 2022-01-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Unable to recruit participants
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251520, "The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04251520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*